$750 Billion in AI CapEx: Who Eats First — The Hyperscaler Hierarchy, Neo Cloud Risk, and Enterprise SaaS Under Pressure

$750 Billion in AI CapEx: Who Eats First — The Hyperscaler Hierarchy, Neo Cloud Risk, and Enterprise SaaS Under Pressure

Amazon, Microsoft, Alphabet, and Meta just collectively committed to over $750 billion in capital expenditure for 2026. They spent $130 billion in a single quarter. That is a 70% increase from what these companies spent in 2025 — and the spending is still accelerating into the second half of the year.


The ROI is showing up. Operating margins are expanding across all four businesses. Google Cloud grew 63% year over year. AWS grew 28%. Microsoft Intelligent Cloud grew 29%. Meta grew revenue 33%. This is not speculative infrastructure spending anymore. These are some of the most profitable businesses ever built, getting more profitable.


But the more important conversation is about what this means for everyone else.


CSI has a framework for understanding how AI infrastructure investment actually flows — and it is the most useful mental model for investors trying to figure out where value accrues in the AI buildout. The hyperscalers eat first. They buy the technology and deploy it internally before any customer touches it. Their strategic investment partners eat second — OpenAI, Anthropic, and others who receive capital and get early infrastructure access. Enterprise software companies and Neo Cloud providers eat third. They get the leftovers, and right now they are scrambling.


This creates two distinct problems. Neo Cloud companies have great infrastructure but no vertical integration — no final product of their own. The moment spare capacity appears in the market, their economics break down rapidly. Enterprise SaaS companies have great products but no infrastructure control — they get stuck waiting for technology that the hyperscalers have already been using internally for years.


CSI lays out what both camps need to do to survive the next phase: Neo Clouds need to start developing software and services of their own before excess capacity forces their hand. Enterprise software companies need to start acquiring infrastructure assets — and there are already early signals that the smarter ones are doing exactly that.


This episode was released to Semi Insider members several weeks before this public version. Members receive CSI's full research, live Q&A sessions, and analysis like this as it happens — not weeks later. If that matters to you, the membership page is at chipstockinvestor.com


What we cover:

— Why hyperscaler earnings reactions are about cashflow expectations not beats or misses

— $750B+ in 2026 AI CapEx — full breakdown across Amazon, Microsoft, Alphabet, and Meta

— Amazon Q1 2026: AWS +28% YoY, operating margin expanding to 13.1%

— Microsoft Q1 2026: Intelligent Cloud +29% YoY, 46.3% operating margin

— Alphabet Q1 2026: Google Cloud +63% YoY, 36.1% operating margin

— Meta Q1 2026: +33% revenue, CapEx raised to $245B, why the stock reaction was muted

— The ROI is real — operating leverage across all four hyperscalers

— The "who eats first" hierarchy — the most useful AI investing framework right now

— Neo Cloud companies — the vertical integration problem and what needs to change

— Enterprise SaaS — why they are chasing the puck and what the smart ones are doing

— Early signals: Salesforce, Snowflake, Fortinet, Trade Desk CapEx moves


Disclosure: Nick and Kasey hold positions in several companies mentioned. This content is for general information only and is not individual investment advice. All investing involves risk.


chipstockinvestor.com

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(492)

Twist Bioscience Soared — We're Still Not Buying

Twist Bioscience Soared — We're Still Not Buying

Twist Bioscience (TWST) just had a massive run-up after Anthropic's protein design results put its DNA synthesis platform in the spotlight. Here's what's really driving the stock — and whether it's st...

17 Sep 14min

The Fastest-Growing Chip Stock Is Also the Most Hated

The Fastest-Growing Chip Stock Is Also the Most Hated

We compare Credo (CRDO) against Broadcom (AVGO), Marvell (MRVL), and Astera Labs (ALAB) on revenue growth, gross margin, operating margin, and free cash flow margin — four fabless companies selling in...

15 Sep 13min

AI Data Center Spending Means Good Times For Semiconductors Continue -- Oracle ORCL Stock Analysis

AI Data Center Spending Means Good Times For Semiconductors Continue -- Oracle ORCL Stock Analysis

We break down the takeaways from Oracle's (ORCL) Q1 fiscal 2027 earnings call — what to expect through 2026 and into 2027–2028 as hyperscaler CapEx stays high but is set to slow in growth by 2027, and...

14 Sep 12min

Nvidia's Biggest Acquisition Ever: $12.9B for Hugging Face (Can It Survive Regulators?)

Nvidia's Biggest Acquisition Ever: $12.9B for Hugging Face (Can It Survive Regulators?)

Nvidia just proposed its largest acquisition ever — $12.9 billion for Hugging Face. But regulators in the US, EU, and China may have other plans.Nvidia has announced plans to acquire Hugging Face, the...

10 Sep 15min

Pure Storage Is Now Everpure — and Free Cash Flow Just Went Negative (P Stock)

Pure Storage Is Now Everpure — and Free Cash Flow Just Went Negative (P Stock)

Pure Storage just rebranded to Everpure — and in the same stretch, free cash flow went negative 20% in a single quarter. Here's what's really going on.Pure Storage has officially rebranded as Everpure...

10 Sep 19min

Procept Is Down 80% and the Tech Works — So Why Won't We Buy PRCT?

Procept Is Down 80% and the Tech Works — So Why Won't We Buy PRCT?

Procept BioRobotics is down roughly 80% from its 2025 highs but the technology behind its Aquablation system genuinely works. So why won't we put PRCT in our portfolio?Procept (PRCT) has one of the mo...

10 Sep 28min

Why Oscar Health's 'Great Quarter' Isn't What It Looks Like

Why Oscar Health's 'Great Quarter' Isn't What It Looks Like

Oscar Health looks like a screaming buy — growing revenue, growing members, positive free cash flow. So why does the market keep discounting it? We ran the numbers.Oscar Health (OSCR) just posted stro...

10 Sep 11min

Palo Alto Is Up 1,400% in a Decade — What Comes Next? (PANW FY2026)

Palo Alto Is Up 1,400% in a Decade — What Comes Next? (PANW FY2026)

Palo Alto Networks (PANW) has been flying high into the end of FY2026. After a decade-long 1,400% run — capped by a broader cybersecurity rally following the Anthropic "Mythos moment" in early 2026 — ...

2 Sep 14min

Populært innen Business og økonomi

stopp-verden
dine-penger-pengeradet
rss-penger-polser-og-politikk
e24-podden
rss-borsmorgen-okonominyhetene
rss-pa-konto
rss-skravla-gar
pengepodden-2
finansredaksjonen
tid-er-penger-en-podcast-med-peter-warren
lederpodden
stormkast-med-valebrokk-stordalen
livet-pa-veien-med-jan-erik-larssen
utbytte
rss-orjasater
pengesnakk
morgenkaffen-med-finansavisen
liberal-halvtime
lydartikler-fra-aftenposten
rss-markedspuls-2